How to read these charts
Against the national standards
Each measure is drawn against its own NHS England standard: 95% for A&E within four hours, 85% for urgent cancer treatment within sixty-two days and 99% for diagnostic tests within six weeks. The charts do not share a standard and the three cancer measures are never added together.
Care Quality Commission
When CQC last rated this body
CQC has not rated Tameside and Glossop Integrated Care NHS Foundation Trust since 4 July 2019. Its judgements from then are still on CQC’s own site and are not shown here, because a rating more than 3 years old is not what CQC currently says about a body.
Monthly performance against national standards
Hover or use the arrow keys to read any month, with the figures the percentage was worked out from. Every chart opens as a table.
A&E Wait Times
Patients seen within four hours
64.2%
August 2026: 64.2 per cent, 6,980 of 10,881 attendances. Below the 95% standard.
All 17 months as a table
| Month | Performance | Of attendances |
|---|---|---|
| Aug 2026 | 64.2%, Below the 95% standard | 6,980 of 10,881 |
| Jul 2026 | 63.8%, Below the 95% standard | 7,495 of 11,746 |
| Jun 2026 | 62.8%, Below the 95% standard | 7,415 of 11,806 |
| May 2026 | 62.4%, Below the 95% standard | 7,388 of 11,845 |
| Apr 2026 | 65.9%, Below the 95% standard | 7,576 of 11,492 |
| Mar 2026 | 68.9%, Below the 95% standard | 8,204 of 11,912 |
| Feb 2026 | 61.0%, Below the 95% standard | 6,456 of 10,579 |
| Jan 2026 | 60.3%, Below the 95% standard | 7,108 of 11,788 |
| Dec 2025 | 63.9%, Below the 95% standard | 7,661 of 11,983 |
| Nov 2025 | 64.7%, Below the 95% standard | 7,803 of 12,069 |
| Oct 2025 | 61.0%, Below the 95% standard | 7,320 of 12,009 |
| Sept 2025 | 65.1%, Below the 95% standard | 7,361 of 11,305 |
| Aug 2025 | 66.0%, Below the 95% standard | 7,068 of 10,706 |
| Jul 2025 | 63.6%, Below the 95% standard | 7,681 of 12,076 |
| Jun 2025 | 58.8%, Below the 95% standard | 6,762 of 11,505 |
| May 2025 | 61.6%, Below the 95% standard | 7,495 of 12,171 |
| Apr 2025 | 66.2%, Below the 95% standard | 7,860 of 11,874 |
Waiting times (RTT)
Referral to treatment: waiting under eighteen weeks to start treatment
78.3%
July 2026: 78.3 per cent, 13,078 of 16,714 people waiting. Below the 92% standard.
All 14 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 78.3%, Below the 92% standard | 13,078 of 16,714 |
| Jun 2026 | 78.3%, Below the 92% standard | 13,155 of 16,793 |
| May 2026 | 77.6%, Below the 92% standard | 13,106 of 16,888 |
| Apr 2026 | 76.5%, Below the 92% standard | 12,468 of 16,288 |
| Mar 2026 | 76.4%, Below the 92% standard | 12,536 of 16,401 |
| Feb 2026 | 74.7%, Below the 92% standard | 12,250 of 16,406 |
| Jan 2026 | 73.3%, Below the 92% standard | 12,458 of 16,987 |
| Dec 2025 | 72.8%, Below the 92% standard | 12,240 of 16,813 |
| Nov 2025 | 73.6%, Below the 92% standard | 12,522 of 17,013 |
| Oct 2025 | 73.7%, Below the 92% standard | 12,607 of 17,118 |
| Sept 2025 | 72.7%, Below the 92% standard | 12,564 of 17,277 |
| Aug 2025 | 70.3%, Below the 92% standard | 12,030 of 17,099 |
| Jul 2025 | 71.7%, Below the 92% standard | 12,326 of 17,204 |
| Jun 2025 | 72.2%, Below the 92% standard | 12,288 of 17,019 |
Diagnostic tests (DM01)
Waiting under six weeks for a scan, a scope or a test
99.2%
July 2026: 99.2 per cent, 3,856 of 3,887 people waiting. Meets the 99% standard.
All 4 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 99.2%, Meets the 99% standard | 3,856 of 3,887 |
| Jun 2026 | 98.7%, Below the 99% standard | 3,300 of 3,344 |
| May 2026 | 98.8%, Below the 99% standard | 3,884 of 3,931 |
| Apr 2026 | 97.9%, Below the 99% standard | 3,759 of 3,841 |
Cancer diagnosis (FDS)
Faster diagnosis standard: told the outcome within twenty-eight days
82.5%
July 2026: 82.5 per cent, 1,106 of 1,341 referrals. Meets the 75% standard.
All 7 months as a table
| Month | Performance | Of referrals |
|---|---|---|
| Jul 2026 | 82.5%, Meets the 75% standard | 1,106 of 1,341 |
| Jun 2026 | 81.9%, Meets the 75% standard | 995 of 1,215 |
| May 2026 | 82.6%, Meets the 75% standard | 926 of 1,121 |
| Apr 2026 | 81.8%, Meets the 75% standard | 969 of 1,185 |
| Mar 2026 | 82.5%, Meets the 75% standard | 1,060 of 1,285 |
| Feb 2026 | 85.8%, Meets the 75% standard | 988 of 1,151 |
| Jan 2026 | 80.1%, Meets the 75% standard | 904 of 1,128 |
Cancer (31-day)
Decision to treat to first treatment within thirty-one days
96.3%
July 2026: 96.3 per cent, 77 of 80 treatments. Meets the 96% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 96.3%, Meets the 96% standard | 77 of 80 |
| Jun 2026 | 96.2%, Meets the 96% standard | 75 of 78 |
| May 2026 | 96.5%, Meets the 96% standard | 55 of 57 |
| Apr 2026 | 98.4%, Meets the 96% standard | 62 of 63 |
| Mar 2026 | 98.8%, Meets the 96% standard | 86 of 87 |
| Feb 2026 | 96.4%, Meets the 96% standard | 53 of 55 |
| Jan 2026 | 100.0%, Meets the 96% standard | 60 of 60 |
Cancer (62-day)
Urgent referral to first treatment within sixty-two days
76.8%
July 2026: 76.8 per cent, 76 of 99 treatments. Below the 85% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 76.8%, Below the 85% standard | 76 of 99 |
| Jun 2026 | 75.7%, Below the 85% standard | 70 of 92.5 |
| May 2026 | 78.7%, Below the 85% standard | 61 of 77.5 |
| Apr 2026 | 80.4%, Below the 85% standard | 61.5 of 76.5 |
| Mar 2026 | 82.6%, Below the 85% standard | 85.5 of 103.5 |
| Feb 2026 | 82.6%, Below the 85% standard | 57 of 69 |
| Jan 2026 | 77.4%, Below the 85% standard | 60 of 77.5 |